BioNTech: COVID-19 Vaccines Manufactured At Marburg Site Scheduled For Distribution In April

(RTTNews) – BioNTech SE (BNTX) said the company’s new BioNTech site will become one of the largest mRNA manufacturing sites in Europe with an annual production capacity of up to 750 million doses of COVID-19 vaccine, once fully operational. The company said the first vaccines manRead MoreMarketsMarkets Feed